What is Growing in My Eye?

(Posted on Tuesday, March 5, 2024)

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. 

In 1999, I defined regenerative medicine as the collection of interventions that restore tissues and organs damaged by disease, injured by trauma, or worn by time to normal function. I include a full spectrum of chemical, gene, and protein-based medicines, cell-based therapies, and biomechanical interventions that achieve that goal.

In the depths of your eyes, a thriving metropolis of microorganisms exists, which could potentially revolutionize our understanding of eye health. Scientists are mapping this frontier, which may bolster our vision and eye health from this microscopic level.

Although the words “bacteria” and “microorganism” may initially evoke thoughts of infection, these tiny creatures are the unsung heroes of our eyes’ microbiome. Their constant watchfulness helps maintain good eye health by fighting off pathogens and regulating the immune system despite being invisible to the naked eye. 

The Eye’s Microbiome Explained

Recent research has shown that, contrary to popular belief, the eye is not an isolated organ and, much like our skin and gut, is host to various microorganisms. The ocular microbiome is rich in microorganisms, especially on the conjunctival membrane. Although the ocular microbiome is less diverse than the skin microbiome, it still contains many microorganisms, approximately 1/100th of the total found on the skin.

The microbiome of our eyes is inhabited by four primary bacterial groups: Staphylococcus, Streptococcus, Propionibacterium, and Corynebacterium. Though these four aren’t the only microorganisms in the eye microbiome, they are often found in the largest quantities. 

Science Supports The Significance of the Eye Microbiome

Over the years, scientists have conducted numerous studies to unravel the connection between the ocular microbiome and various eye diseases. These studies have revealed that an imbalance in the microbial population in the eyes can trigger inflammation, leading to several conditions, such as chronic dry eye and blepharitis.

For example, chronic dry eye is a common condition that affects individuals of all ages. It occurs when the eyes fail to produce sufficient tears to lubricate the eye surface, resulting in dryness, irritation, and discomfort. Multiple factors, including age, medications, and environmental elements, can contribute to this condition. However, recent research suggests that an imbalance in the ocular microbiome may also play a role.

Researchers continue to delve into these clinical enigmas, aiming to identify the underlying causes of these conditions and develop targeted treatment approaches. The implications of this research can potentially revolutionize the treatment of ocular diseases.

Potential Therapeutic Strategies and Beyond

The complexity of the eye’s microbiome is being increasingly recognized, and with that recognition comes the responsibility to maintain its delicate balance. Age, ethnicity, geographic location, and lifestyle choices like wearing contact lenses can all affect the microbiome’s equilibrium, leading to adverse health outcomes. Awareness of these factors can help prevent disruptions in the ocular microbiome’s harmony.

Scientists are using their newfound knowledge to develop treatments that target imbalances in the microbiome. Different treatments, such as antibiotics, phage therapy, and probiotics, are available, each with unique challenges and opportunities. While antibiotics can eradicate harmful bacteria, they can also disrupt beneficial ones. On the other hand, phage therapy offers precision in eliminating unwanted bacterial growth. Probiotics are also a potential solution as they can modulate the gut microbiome and improve ocular health.

Our understanding of the microbiome is evolving, leading us towards treatment and prevention. Through groundbreaking research, we are identifying pathways that could reduce the risk of eye diseases and maintain microbial equilibrium to prevent them from developing. This shift in perspective is significant as it acknowledges the potential of harnessing the microbiome’s power to prevent diseases from taking root.

The ocular microbiome holds immense potential for researchers who seek to understand its impact on eye health. Our current knowledge is only the tip of the iceberg, and future studies will delve deeper into the microbiome’s interactions with various eye conditions. These findings could lead to the development of novel treatments that enhance our quality of life.

To learn more about the eye, read more stories at www.williamhaseltine.com